ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,814 | +186.9% | 7,738 | +268.0% | 0.00% | 0.0% |
| Q2 2023 | $16,319 | +30690.6% | 2,103 | -76.8% | 0.00% | -50.0% |
| Q4 2022 | $53 | -99.8% | 9,077 | +30.3% | 0.00% | – |
| Q3 2022 | $22,000 | -60.0% | 6,967 | -42.4% | 0.00% | -100.0% |
| Q2 2022 | $55,000 | -41.5% | 12,093 | -31.0% | 0.00% | 0.0% |
| Q1 2022 | $94,000 | +683.3% | 17,530 | +2056.2% | 0.00% | – |
| Q4 2021 | $12,000 | -77.4% | 813 | -67.6% | 0.00% | -100.0% |
| Q3 2021 | $53,000 | +65.6% | 2,510 | +34.7% | 0.00% | 0.0% |
| Q2 2021 | $32,000 | -15.8% | 1,863 | +20.0% | 0.00% | 0.0% |
| Q1 2021 | $38,000 | -57.3% | 1,552 | -41.1% | 0.00% | -66.7% |
| Q4 2020 | $89,000 | -53.9% | 2,635 | -65.9% | 0.00% | +50.0% |
| Q3 2020 | $193,000 | +1186.7% | 7,728 | +1664.4% | 0.00% | +100.0% |
| Q2 2020 | $15,000 | – | 438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |